Diagonal Bio AB is a MedTech company based in Lund (Sweden), founded in 2020. Our goal is to fundamentally change the infectious disease testing landscape as we know it today.
Founded during the Covid-19 crises towards a transition to become a professional company with major growth ambitions on the path to listing on Nasdaq First North Growth Market.
Major steps from the initial startup founded during the Covid-19 Crises towards a transition to become a professional company with major growth ambitions on the path to listing on Nasdaq First North Growth Market. We have come a long way in a very short time and continue to optimize and focus our effort to get the first product to market and we are confident in the opportunities to continue to develop as a commercial company driven by a strong and experienced team that will enable us to continue at the same high pace during the rest of the year.
This is truly an exciting journey with the potential to limit the spread of disease worldwide, hence our efforts will have a direct impact on the lives and health of individuals at a global scale.